Press "esc" to clear
Go to Advanced Search

Showing results

110 of 443

Article ID: 696162

University Hospitals selects 2bPrecise to deliver genomic insights at point of care

University Hospitals Cleveland Medical Center

University Hospitals has selected the 2bPrecise platform to make genomic data points more accessible to physicians allowing for the data to be part of the medical record and subsequently shape and tailor the best treatment or therapy options for patients.

Released:
14-Jun-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696079

Mayo Clinic discovery is first step toward new bacteria-based constipation treatment

Mayo Clinic

Genetically engineered bacteria are showing promise as a new treatment for constipation, researchers at the Mayo Clinic Center for Individualized Medicine have discovered in a mouse study. The finding is significant in part because there are few approved constipation remedies on the market. The research is published in Cell Host & Microbe.

Released:
13-Jun-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 695955

Researchers Identify Dozens of New Gene Changes That Point to Elevated Risk of Prostate Cancer in Men of European Descent

Case Western Reserve University

As the result of a six-year long research process, Fredrick R. Schumacher, PhD, a cancer epidemiology researcher at Case Western Reserve University School of Medicine, and an international team of more than 100 colleagues have identified 63 new genetic variations that could indicate higher risk of prostate cancer in men of European descent. The findings, published in a research letter in Nature Genetics, contain significant implications for which men may need to be regularly screened because of higher genetic risk of prostate cancer.

Released:
11-Jun-2018 3:45 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
1491301910.png

Article ID: 695670

Understanding Cancer Heterogeneity Could Further Reduce Chemo Use, Says Expert

Sbarro Health Research Organization (SHRO)

Released:
6-Jun-2018 11:35 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 695667

UNLV Awarded $11.4 Million Federal Grant to Advance Personalized Medicine in Nevada

University of Nevada, Las Vegas (UNLV)

UNLV was recently awarded an $11.4 million grant from the National Institutes of Health (NIH) to build Nevada’s first center of excellence in personalized medicine. The five-year award marks the first time UNLV will lead a project funded through the NIH’s competitive Center of Biomedical Research Excellence (COBRE) program. It’s also believed to be the first COBRE program in the nation focused exclusively on personalized medicine.

Released:
5-Jun-2018 8:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 695359

Philips and Dana-Farber operationalize and scale Clinical Pathways

Dana-Farber Cancer Institute

he Dana-Farber Clinical Pathways will be deployed through the Philips IntelliSpace Oncology Platform, providing clinical decision support to physicians via a patient-centric solution.

Released:
31-May-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
BrainTumorLindaTestTube.jpg

Article ID: 695304

Personalized cancer vaccine may increase long-term survival in patients with deadly brain cancer

University of California, Los Angeles (UCLA), Health Sciences

An international study led by researchers at UCLA has found that a personalized vaccine targeting glioblastoma, the deadliest form of brain cancer, may help people live longer. Nearly 30 percent of people in the current trial have now survived for at least three years after receiving the vaccine.

Released:
30-May-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 695111

Fred Hutch Scientists to Feature Health Economics, Next-Gen Immunotherapy, Health Disparities and More at ASCO

Fred Hutchinson Cancer Research Center

Fred Hutchinson Cancer Research Center’s latest findings will be featured at the annual meeting of the American Society of Clinical Oncology, “Delivering Discoveries: Expanding the Reach of Precision Medicine,” to be held June 1–5 in Chicago. Here are several highlights:

Released:
24-May-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 694781

Mayo Clinic identifica posible alternativa terapéutica para cáncer de mama triple negativo

Mayo Clinic

Un fármaco utilizado en el cáncer sanguíneo puede resultar útil en el cáncer de mama triple negativo, descubrieron los investigadores de Mayo Clinic. El cáncer de mama triple negativo es uno de los tipos más agresivos y letales de cáncer de mama. El estudio se publicó en la Revista de Investigación Clínica.

Released:
17-May-2018 4:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 649790

Inside Cancer Cells, Tumor Growth in Kidney Cancer, Genetic Screening Guidelines, and More in the Cancer News Source

Newswise

Click here to go directly to the Cancer News Source

Released:
11-May-2018 3:15 PM EDT
EXPERT AVAILABLE
Open in New Tab Add to Favorites
Comment

Showing results

110 of 443





Chat now!